-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Initiates Coverage On Alto Neuroscience with Buy Rating, Announces Price Target of $27

Benzinga·11/17/2025 10:49:32
Listen to the news
BTIG analyst Thomas Shrader initiates coverage on Alto Neuroscience (NYSE:ANRO) with a Buy rating and announces Price Target of $27.